255 related articles for article (PubMed ID: 4598802)
1. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
Meyer-Rienecker H; Hitzschke B
Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
[No Abstract] [Full Text] [Related]
2. [Clinical picture and therapy of multiple sclerosis].
Schrader A
Wien Med Wochenschr; 1972 Mar; 122(10):129-34. PubMed ID: 4334261
[No Abstract] [Full Text] [Related]
3. [Review of the therapy of multiple sclerosis].
De Rosa A; Puccini A; De Martino V
Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
[No Abstract] [Full Text] [Related]
4. [Multiple sclerosis].
Igata A
Nihon Rinsho; 1970 Jul; 28(7):1886-91. PubMed ID: 4918043
[No Abstract] [Full Text] [Related]
5. [Encephalomyelitis disseminata (also called multiple sclerosis)].
Meyer G
Fortschr Med; 1973 May; 91(14):611-5. PubMed ID: 4734084
[No Abstract] [Full Text] [Related]
6. Symposium on etiology, diagnosis and treatment of multiple sclerosis. Recent concepts of etiology: implications for treatment.
Silberberg DH
Mod Treat; 1970 Sep; 7(5):879-89. PubMed ID: 4933353
[No Abstract] [Full Text] [Related]
7. [Immunosuppressive treatment in neurological disorders].
Aarli JA
Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
[No Abstract] [Full Text] [Related]
8. Proceedings: Intensive immunosuppression in multiple sclerosis.
Lance EM; Abbosh J; Kremer M; Jones V; Knight S; Medawar P
Neurology; 1975 May; 25(5):491. PubMed ID: 1169713
[No Abstract] [Full Text] [Related]
9. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
Thompson RF; Davenport J
Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
[No Abstract] [Full Text] [Related]
10. [Multiple sclerosis. Studies on etiology and therapy].
Bauer HJ
MMW Munch Med Wochenschr; 1982 Jan; 124(4):69-70. PubMed ID: 6801481
[No Abstract] [Full Text] [Related]
11. [Treatment of multiple sclerosis (recent concepts)].
Marteau R
Rev Med Liege; 1972 Aug; 27(16):543-6. PubMed ID: 5052716
[No Abstract] [Full Text] [Related]
12. [Immunodepressive agents in neurology].
Sabouraud O
Rev Prat; 1986 Jan; 36(5):229-36. PubMed ID: 2870559
[No Abstract] [Full Text] [Related]
13. [Multiple sclerosis].
Steck AJ
Rev Med Suisse Romande; 1984 Mar; 104(3):231-8. PubMed ID: 6326241
[No Abstract] [Full Text] [Related]
14. [Immunodepressors in ophthalmology].
Bonnet M
Annee Ther Clin Ophtalmol; 1971; 22():117-55. PubMed ID: 4356770
[No Abstract] [Full Text] [Related]
15. [Use of immunosuppressive agents in the therapy of systemic connective tissue disorders].
Berović Z
Reumatizam; 1972; 19(6):217-20. PubMed ID: 4657801
[No Abstract] [Full Text] [Related]
16. [Current data on the etiopathogenesis of multiple sclerosis].
Duca E
Neurol Psihiatr Neurochir; 1972; 17(5):385-94. PubMed ID: 4632587
[No Abstract] [Full Text] [Related]
17. [Immunosuppressive treatment and its side effects].
Scheiffarth F
Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064
[No Abstract] [Full Text] [Related]
18. The possible role of measles virus in the pathogenesis of multiple sclerosis.
Pette E; Palacios O
Int Arch Allergy Appl Immunol; 1969; 36():Suppl:102-8. PubMed ID: 4392027
[No Abstract] [Full Text] [Related]
19. [Glial migration inhibition test in multiple sclerosis patients and its changes during treatment with immunosuppressants].
Kogan OG; Kanchurin AKh; Kuznetsova OV; Brusina LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1798-1802. PubMed ID: 7340320
[TBL] [Abstract][Full Text] [Related]
20. Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.
Cendrowski W
Boll Ist Sieroter Milan; 1979 Sep; 58(4):339-43. PubMed ID: 553516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
